50% off Premium Yearly

TSE:L
This summary was created by AI, based on 11 opinions in the last 12 months.
Loblaw Companies Ltd, a leading food and drug retailer in Canada, has experienced significant growth, especially following its acquisition of Shoppers Drug Mart. Experts note its strong performance amid food inflation, and the success of its No Frills discount brand has drawn positive attention. However, concerns about overvaluation are prevalent, with many analysts watching for signs of sustainable growth, especially with increasing competition from Walmart and Costco. While some view the company as a solid defensive investment, others are cautious, indicating that current valuations appear stretched compared to historical standards. Analysts provide mixed views on its future performance, recommending investors consider alternatives in the retail space.
This is a company that is doing everything right. Increasing their national footprint. Expect synergies and cost savings with its integration with Shoppers. Valuation is high, but it reflects the fact that we are still 40%-45% off in terms of the price of energy, which has implications for the consumer which he thinks are going to be long-lasting. Also, this is a more defensive area to hang out in.
Empire Company (EMP.A-T) or Loblaw’s (L-T)? The grocery space is a fairly consolidated market with 3 or 4 major players and relatively defensive. With the exit of Target, the square footage as really moderated, this is a plus. If she had to choose among all the players out there, it would be this one, because of the drug retail side.
Has had a fantastic run. Part of that is because the stock had languished for many, many years. In the last few years they have monetized their real estate holdings through a REIT, improved their operational results, improved margins as well as acquiring Shoppers. You probably want to stick with this one.
(Top Pick Mar 5/14, Up 29.65%) She bought when they had just completed the Shoppers acquisition and were having problems rolling out SAP. The stock had pulled back. Things are largely working now and they are seeing the benefits. Target was a concern and they have exited. We are starting to see cross selling between the two chains. She would buy it here.
Just reported good earnings and also at a record high. This is your classic consumer staples name. Very steady and predictable growth along with a modest but growing dividend. They will probably grow their dividend at a 5% clip per year over the next several years. A lot of their capital expenditures are behind them, so you will see that in the earnings and you will see the benefits of those renovations going forward. The acquisition of Shoppers Drug Mart will certainly provide this grocery giant exposure to higher-margin profile. Trading pretty nicely at 18X forward earnings with a 15% growth rate. Dividend yield of 1.54%.
Good company and have a good move up in earnings coming because of their Shoppers acquisition. Their basic food business is pretty brutal. Lots of competition. Without food inflation it is pretty hard for them to get their prices up. Yield is reasonably low, but they are increasing their dividends at a gradual rate.
(A Top Pick May 6/14. Up 36.18%.) This was picked right after Shoppers was closed. Stock had pulled back because of weak numbers on their grocery side, and she felt it was a good time to get in. We are still going to see a lot of benefit coming through from the acquisition. There will be an increasing free cash flow. She has a price target of about $70 in 12 months.